Determination of Solifenacin in human plasma by LC-MS/MS method

Thi La Le , Ngoc Cuong Cao, Thi Nghia Phan, Thi Hoai Thuong Nguyen, Thi Cham Nguyen, Thi Thuy Truong

Main Article Content

Abstract

A high and specific method using ultra performance liquid chromatography tandem mass spectrometry for determination of solifenacin in human plasma was developed. Solifenacin-d5 were utilized as internal standard. Analytes were extracted from plasma by liquid-liquid extraction method using tert-butyl methyl ether. Liquid chromatography was performed on Hypersil Gold C18; 50 x 2.1 mm; 1.9 µm column with of 5 mM ammonium acetate, with 0.1% formic acid and acetonitrile as mobile phase at flow rate of 0.2 mL per minute. The method has a rapid analysis time and LLOQ value and standard curves were found to be linear in the wide range 0.1 to 25.0 ng/mL. The method’s precision and accurary are within acceptable limit. The validated method has been used successfully to determine solifenacin concentration in healthy adult volunteers and demonstrate its applicability to bioavailability/bioequivalence studies of solifenacin preparations.

Article Details

References

1. Solifenacin 10 mg film-coated tablets - Summary of Product Characteristics (SmPC) (emc) | 10428. Accessed April https://www. medicines.org.uk/emc/product/10428/smpc#gref.
2. European Medicines Agency (2009), Assessment report for irbesartan/ solifenacin Teva, Procedure No. EMEA/H/C/001112
3. Faculty of Pharmacy and Medical Sciences, Al-Ahliyya Amman University, Jordan, “Quantitation of Solifenacin in Human Plasma using a Specific and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Technique”, Tropical Journal of Pharmaceutical Research May 2015; Pages 845-851
4. Srinivasa Babu Puttagunta, Rihana Parveen Shaik, Chandrasekhar Kothapalli Bannoth, Bala Sekhara Reddy Challa and Bahlul Zayed Sh Awen, “Bioanalytical method for quantification of Solifenacin in rat plasma by LC-MS/MS and its application to pharmacokinetic study”, Puttagunta et al. Journal of Analytical Science and Technology 2014.
5. DoHwanKim, Myoung Jin Ho, ChanKyuJeong and MyungJooKang, “Novel Bioequivalent Tablet of Solifenacin Succinate Prepared Using Direct Compression Technique for Improved Chemical Stability”, https://doi.org/10.3390/pharmaceutics15061723.
6. Jan Macek, Pavel Ptácek, Josef Klíma, “Determination of solifenacin in human plasma by liquid chromatography–tandem mass spectrometry”, Journal Chromatography B, Volume 878, Issue 31, Pages 3327 – 3330.
7. U.S. Department of Health and Human Services Food and Drug Administration (2018), Guidance for industry-Bioanalytical method validation.
8. European Medicines Agency, Committee for Medicinal Products for Human Use (2012), Guideline on Validation of Bioanalytical Methods
9. International council for harmonization of technical requirements for pharmaceuticals for human use (2022), “Bioanalytical method validation and study sample analysis M10”
10. National Center for Biotechnology Information, National Library of Medicine, https://pubchem.ncbi.nlm.nih.gov/compound/solifenacin